| 产品描述: | Ivospemin (SBP-101) is an antineoplastic spermine analog. Ivospemin has shown efficacy in slowing pancreatic and ovarian tumor progression in vitro and in vivo. Ivospemin shows modest induction of polyamine catabolism, but stronger repression of ornithine decarboxylase activity. Ivospemin is promising for research of cancers. |
| 体外研究: |
Ivospemin (24 mg/kg,腹腔注射,2 周一次,连续 3 次,交替周数,持续 60 天) 在小鼠卵巢腺癌模型中通过推迟疾病发作并减少总体肿瘤负担,增加了生存率[2][3]。 |
| 体内研究: |
Ivospemin (500 nM 至 10 µM,96 小时) 降低人类卵巢腺癌细胞的细胞活力,IC50 值范围在 0.95 µM 到 3.24 µM 之间,与顺铂敏感性无关。 Ivospemin 处理后人类卵巢腺癌细胞系后的 IC50 值 |
| 参考文献: |
1. International Nonproprietary Names for Pharmaceutical Substances (INN). 2. Holbert CE, et al. The Polyamine Analogue Ivospemin Increases Chemotherapeutic Efficacy in Murine Ovarian Cancer. Biomedicines. 2024 May 23;12(6):1157. 3. Liu TA, et al. The Synergistic Benefit of Combination Strategies Targeting Tumor Cell Polyamine Homeostasis. Int J Mol Sci. 2024 Jul 26;25(15):8173. |
| 保存条件: |
-80°C 6个月;-20°C 1个月 |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
3.14 ml |
15.699 ml |
31.397 ml |
| 5 mM |
0.628 ml |
3.14 ml |
6.279 ml |
| 10 mM |
0.314 ml |
1.57 ml |
3.14 ml |
| 50 mM |
0.063 ml |
0.314 ml |
0.628 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |